HMGB1 and neoplasm: Alternatively, there are antioxidants to inhibit HMGB1 release, leading to the suppression of cell death and inflammatory responses 38; furthermore, ROS has been considered as a promoter for tumour angiogenesis in vivo, which could be attenuated by different antioxidants 16.